Sorin Group Makes Minority Investment in Respicardia
Medical device company Sorin Group has made a $20 million minority investment in Respicardia, a developer of implantable therapies to improve Respiratory Rhythm Management. Under the terms of the transaction, Sorin acquired the...
Read More